We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Stock Moves -0.07%: What You Should Know
Read MoreHide Full Article
The most recent trading session ended with UnitedHealth Group (UNH - Free Report) standing at $524.70, reflecting a -0.07% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss of 0.23%. Meanwhile, the Dow lost 0.91%, and the Nasdaq, a tech-heavy index, added 0.1%.
The largest U.S. health insurer's stock has climbed by 6.4% in the past month, exceeding the Medical sector's loss of 10.2% and the S&P 500's loss of 12.13%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on April 17, 2025. The company is expected to report EPS of $7.27, up 5.21% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $111.01 billion, up 11.24% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of $29.73 per share and a revenue of $451.2 billion, demonstrating changes of +7.48% and +12.72%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection has moved 0.31% higher. UnitedHealth Group is currently a Zacks Rank #2 (Buy).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 17.66. Its industry sports an average Forward P/E of 14.19, so one might conclude that UnitedHealth Group is trading at a premium comparatively.
Meanwhile, UNH's PEG ratio is currently 1.42. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - HMOs was holding an average PEG ratio of 1.16 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 156, positioning it in the bottom 38% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Stock Moves -0.07%: What You Should Know
The most recent trading session ended with UnitedHealth Group (UNH - Free Report) standing at $524.70, reflecting a -0.07% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss of 0.23%. Meanwhile, the Dow lost 0.91%, and the Nasdaq, a tech-heavy index, added 0.1%.
The largest U.S. health insurer's stock has climbed by 6.4% in the past month, exceeding the Medical sector's loss of 10.2% and the S&P 500's loss of 12.13%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on April 17, 2025. The company is expected to report EPS of $7.27, up 5.21% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $111.01 billion, up 11.24% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of $29.73 per share and a revenue of $451.2 billion, demonstrating changes of +7.48% and +12.72%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection has moved 0.31% higher. UnitedHealth Group is currently a Zacks Rank #2 (Buy).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 17.66. Its industry sports an average Forward P/E of 14.19, so one might conclude that UnitedHealth Group is trading at a premium comparatively.
Meanwhile, UNH's PEG ratio is currently 1.42. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - HMOs was holding an average PEG ratio of 1.16 at yesterday's closing price.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 156, positioning it in the bottom 38% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.